Results
|
|
1.
|
I-124 PET/CT versus conventional radioiodine imaging in differentiated thyroid cancer: a review. MedStar authors:
- Burman, Kenneth D
- Heimlich, S Layla
- Van Nostrand, Douglas
- Wartofsky, Leonard
- Wu, Di
- Ylli, Dorina
Year: 2019
Citation: - Thyroid. 29(11):1523-1535, 2019 11.
Institution:
- MedStar Health Research Institute
- MedStar Washington Hospital Center
Department:
- Library
- Medicine/Endocrinology
- Medicine/Nuclear Medicine
Medline publication type:
All authors: - Burman KD, Heimlich SL, Van Nostrand D, Wartofsky L, Wu D, Ylli D
|
|
|
2.
|
PET/CT scan and biopsy-driven approach for safe anti-PD-1 therapy discontinuation in patients with advanced melanoma. MedStar authors:
- Al-Refaie, Waddah B
- Petronic-Rosic, Vesna
- Radfar, Arash
- Zaemes, Jacob
Year: 2021
Citation: - Journal for Immunotherapy of Cancer. 9(10), 2021 10.
Institution:
- MedStar Health Research Institute
- MedStar Washington Hospital Center
Department:
- Dermatology
- Internal Medicine Residency
- MedStar Georgetown University Hospital
Medline publication type:
All authors: - Al-Refaie WB, Atkins MB, Gardner K, Gibney GT, Petronic-Rosic V, Radfar A, Rapisuwon S, Reilly MJ, Shah NJ, Shand S, Swoboda D, Zaemes J
|
|
|
3.
|
Recombinant human thyroid-stimulating hormone versus thyroid hormone withdrawal in 124I-PET/CT based dosimetry for 131I therapy of metastatic differentiated thyroid cancer. MedStar authors:
- Atkins, Francis
- Garcia, Carlos
- Van Nostrand, Douglas
Year: 2017
Citation: - Journal of Nuclear Medicine. 58(7):1146-1154, 2017 Jul
Institution: - MedStar Washington Hospital Center
Department: - Medicine/Nuclear Medicine
Medline publication type:
All authors: - Atkins F, Garcia C, Hobbs RF, Huang K, Plyku D, Sgouros G, Van Nostrand D
|
